Trial Profile
Ambulatory Blood Pressure Monitoring in Rivaroxaban Therapy
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 13 Aug 2020
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Cardiovascular disorders
- Focus Adverse reactions
- 10 Aug 2020 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 09 Sep 2015 New trial record